EUVIMEDEUVIMED entdecken
Crossref

Prognostic factors for 5 year relapse-free survivors following curative resection for stage II/III colorectal cancer

Takeru Itoi, Hideo Miyake, Hidemasa Nagai, Yuichiro Yoshioka, Junichi Takamizawa, Norihiro Yuasa

Surgery Today · 2025

DOI: 10.1007/s00595-025-03157-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery Today, 2025. Verfasst von Takeru Itoi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, Nagoya, 45…. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Colorectal Neoplasms, Colectomy, Cancer Survivors. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: With an increasing number of individuals surviving colorectal cancer (CRC), it is important to identify prognostic factors to determine follow-up strategies beyond 5 years. This study investigated the clinical factors associated with the overall survival (OS), disease-specific survival (DSS), and non-disease-specific survival (NDSS) in survivors who remained relapse-free for 5 years following curative resection for stage II/III CRC. METHODS: Among 1536 patients who underwent curative resection for stage II/III CRC between 2003 and 2018, 881 who remained relapse-free for 5 years were included. The OS, DSS, and NDSS beyond 5 years were analyzed using univariate and multivariate methods. RESULTS: The mean age was 77.5 years, and 54.6% were male. During a median follow-up of 34 months beyond 5 years, 87 individuals died (5 disease-specific and 73 non-disease-specific). The 5 year OS, DSS, and NDSS rates were 92%, 99%, and 92%, respectively. Multivariate analysis identified age ≥ 80 years, serum carcinoembryonic antigen ≥ 5.0 ng/mL, anemia, mean corpuscular volume ≥ 100 fL, and red cell distribution width (RDW) ≥ 14.9% as independent predictors of a poor OS. CONCLUSIONS: Five clinical factors-age ≥ 80 years, elevated CEA level, anemia, macrocytosis, and a high RDW-were identified as independent prognostic indicators among 5 year relapse-free survivors after stage II/III CRC resection. These findings highlight the importance of individualized long-term follow-up strategies, even beyond 5 years after surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm Recurrence, LocalColorectal NeoplasmsColectomyCancer SurvivorsPrognosisNeoplasm StagingDisease-Free SurvivalHumansMaleFemaleAgedFollow-Up StudiesSurvival RateAge FactorsCarcinoembryonic AntigenAnemiaRisk FactorsErythrocyte IndicesTreatment OutcomeRetrospective StudiesAged, 80 and overTime FactorsMultivariate Analysis

Stichwörter der Autor:innen

Colorectal cancerMean corpuscular volumeRed cell distribution widthRelapse-free survivorSurvival

Substanzen

Carcinoembryonic Antigen

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, Nagoya, 453-8511, Japan.
  • Department of Laboratory Medicine, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, Nagoya, 453-8511, Japan.
  • Department of Gastrointestinal Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, Nagoya, 453-8511, Japan. nyuasa0257@gmail.com.
  • Department of Laboratory Medicine, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, 3-35 Michishita-cho, Nakamura-ku, Nagoya, 453-8511, Japan. nyuasa0257@gmail.com.

Zitieren

APA

Itoi, T., Miyake, H., Nagai, H., Yoshioka, Y., Takamizawa, J., & Yuasa, N. (2025). Prognostic factors for 5 year relapse-free survivors following curative resection for stage II/III colorectal cancer. Surgery Today. https://doi.org/10.1007/s00595-025-03157-0

Vancouver

Itoi T, Miyake H, Nagai H, Yoshioka Y, Takamizawa J, Yuasa N. Prognostic factors for 5 year relapse-free survivors following curative resection for stage II/III colorectal cancer. Surgery Today. 2025. doi:10.1007/s00595-025-03157-0

BibTeX
@article{Itoi2025,
  author = {Itoi, Takeru and Miyake, Hideo and Nagai, Hidemasa and Yoshioka, Yuichiro and Takamizawa, Junichi and Yuasa, Norihiro},
  title = {Prognostic factors for 5 year relapse-free survivors following curative resection for stage II/III colorectal cancer},
  journal = {Surgery Today},
  year = {2025},
  doi = {10.1007/s00595-025-03157-0}
}
Kostenlos starten →